首页> 外文期刊>Frontiers of chemical science and engine >Synthesis and characterization of biocompatible polyurethanes for controlled release of hydrophobic and hydrophilic drugs
【24h】

Synthesis and characterization of biocompatible polyurethanes for controlled release of hydrophobic and hydrophilic drugs

机译:用于疏水和亲水药物控制释放的生物相容性聚氨酯的合成与表征

获取原文
获取原文并翻译 | 示例
           

摘要

Design of biocompatible and biodegradable polymer systems for sustained and controlled release of bioactive agents is critical for numerous biomedical applications. Here, we designed, synthesized, and characterized four polyurethane carrier systems for controlled release of model drugs. These polyurethanes are biocompatible and biodegradable because they consist of biocompatible poly(ethylene glycol) or poly(caprolactone diol) as soft segment, linear aliphatic hexamethylene diisocyanate or symmetrical aliphatic cyclic dicyclohex-ylmethane-4,4'-diisocyanate as hard segment, and biodegradable urethane linkage. They were characterized with Fourier transform infrared spectroscopy, atomic force microscope, and differential scanning calorimetry, whereas their degradation behaviors were investigated in both phosphate buffered saline and enzymatic solutions. By tuning polyurethane segments, different release profiles of hydrophobic and hydrophilic drugs were obtained in the absence and presence of enzymes. Such difference in release profiles was attributed to a complex interplay among structure, hydrophobicity, and degradability of polyurethanes, the size and hydrophobicity of drugs, and drug-polymer interactions. Different drug-polyurethane combinations modulated the distribution and location of the drugs in polymer matrix, thus inducing different drug release mechanisms. Our results highlight an important role of segmental structure of the polyurethane as an engineering tool to control drug release.
机译:对于许多生物医学应用而言,设计用于持续和控制释放生物活性剂的生物相容性和生物可降解聚合物系统至关重要。在这里,我们设计,合成和表征了四种用于控制模型药物释放的聚氨酯载体系统。这些聚氨酯具有生物相容性和可生物降解性,因为它们由生物相容性聚(乙二醇)或聚己内酯二醇(作为软链段),线性脂肪族六亚甲基二异氰酸酯或对称的脂肪族环状二环己基甲烷-4,4'-二异氰酸酯作为硬链段组成,并且可生物降解氨基甲酸酯键。用傅里叶变换红外光谱,原子力显微镜和差示扫描量热法对其进行了表征,而它们的降解行为则在磷酸盐缓冲液和酶溶液中进行了研究。通过调节聚氨酯链段,在不存在和存在酶的情况下,可获得疏水和亲水药物的不同释放曲线。释放曲线的这种差异归因于聚氨酯的结构,疏水性和可降解性,药物的大小和疏水性以及药物-聚合物相互作用之间的复杂相互作用。不同的药物-聚氨酯组合可调节药物在聚合物基质中的分布和位置,从而诱导不同的药物释放机制。我们的结果突出了聚氨酯的片段结构作为控制药物释放的工程工具的重要作用。

著录项

  • 来源
    《Frontiers of chemical science and engine》 |2014年第4期|498-500|共3页
  • 作者单位

    Department of Chemical and Biomolecular Engineering, The University of Akron, Akron, OH 44325, USA;

    Department of Chemical and Biomolecular Engineering, The University of Akron, Akron, OH 44325, USA;

    Department of Biomedical Engineering, University at Buffalo, State University of New York, Buffalo, NY 14260, USA;

    Department of Biomedical Engineering, University at Buffalo, State University of New York, Buffalo, NY 14260, USA,Department of Chemical and Biological Engineering, University at Buffalo, State University of New York, Buffalo, NY 14260, USA;

    Department of Chemical and Biomolecular Engineering, The University of Akron, Akron, OH 44325, USA;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    polyurethanes; controlled release; drug delivery; phase structure; degradation;

    机译:聚氨酯控释;药物输送;相结构降解;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号